Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 10.3M | 11.5M | 10.7M | 11.9M |
Cost of revenue | 5.0M | 5.5M | 5.4M | 5.6M |
Gross profit | 5.3M | 6.1M | 5.3M | 6.3M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 3.8M | 7.6M | 3.7M | 3.5M |
Other operating expenses | — | — | — | — |
Operating income | 1.6M | -1.5M | 1.6M | 2.7M |
Non operating interest income | ||||
Income | 1K | 6K | 14K | — |
Expense | 275K | 278K | 218K | 193K |
Other income expense | — | — | — | — |
Pretax income | 1.3M | -1.8M | 1.4M | 2.6M |
Tax provision | 545K | 827K | 567K | 755K |
Net income | 747K | -2.6M | 824K | 1.8M |
Basic EPS | 0.0 | 0.0 | 0.0 | — |
Diluted EPS | 0.0 | 0.0 | 0.0 | — |
Basic average shares | 309.8M | 309.8M | 255.6M | — |
Diluted average shares | 309.8M | 309.8M | 255.6M | — |
EBITDA | 3.0M | -467.6K | 3.3M | 3.9M |
Net income from continuing op. | 1.3M | -1.8M | 1.4M | 2.6M |
Minority interests | -23K | 7K | -65K | 98K |
Preferred stock dividends | 0 | 0 | 0 | 0 |